Premium
Function analysis of the different S6Ks isoforms (752.8)
Author(s) -
Pavan Isadora,
Ferreira Flávia,
Freitas Lidia,
Tavares Mariana,
Simabuco Fernando
Publication year - 2014
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.28.1_supplement.752.8
Subject(s) - p70 s6 kinase 1 , gene isoform , pi3k/akt/mtor pathway , alternative splicing , microbiology and biotechnology , biology , ribosomal protein s6 , function (biology) , signal transduction , gene , biochemistry
mTOR signaling pathway has been related to several human diseases and disorders, including obesity, diabetes and many types of cancer. In the cell, mTOR signaling is responsible to induce cell growth and metabolism upon activation by signals from nutrients processing, such as insulin, ATP and amino acids. S6Ks, the known kinases of ribosomal small subunit S6 protein, are effectors of mTOR response. S6K family is composed of two genes (encoding S6K1 and S6K2) and different isoforms from alternative translation initiation (p70‐S6K1, p85‐S6K1, p54‐S6K2, p56‐S6K2) and alternative splicing (p31‐S6K1). The main function of S6Ks, upon activation, is to lead to increased protein synthesis. Nevertheless, one of the main questions in this field is to address the specific roles of the different S6Ks isoforms. In this study, we overexpressed p70‐S6K1, p85‐S6K1, p54‐S6K2, p31‐S6K1 in human cells and analyzed by immunoprecipitation followed by mass spectrometry identification the possible and different interacting partners of those S6Ks isoforms. The different roles of S6Ks isoforms was then evaluated in an adipocyte model and in cancer cell lines. Our study may provide new functions to the different S6Ks isoforms which may help the understanding of their roles in the mTOR signaling pathway. Grant Funding Source : Suported by FAPESP #2012/13558‐7